Open Payments

KENNETH B PUGAR

Type
Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology
Where
CENTERVILLE, OH
NPI
1528060399
Received
$596,194 in 1,516 records, 2019 to 2025 ($581,669 general, $14,525 research); ownership interests with $266,513 invested
As principal investigator
$1,325,404 of research payments to others in 303 records
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2025General payment181$88,688
2024General payment203$87,150
2023General payment184$55,792
2022General payment238$81,435
2021General payment285$133,053
2020General payment187$56,357
2020Research payment2$5,525
2019General payment230$79,192
2019Ownership or investment interest2$266,513
2019Research payment4$9,000

By company

CompanyRecordsAmountYears
Renovis Surgical Technologies, Inc.2$266,5132019
EMD Serono, Inc.235$218,2592019–2025
Biogen, Inc.190$183,4842019–2025
GENZYME CORPORATION73$58,1532019–2025
Eisai Inc.62$37,8482020–2025
Lilly USA, LLC92$31,0102019–2025
Avanir Pharmaceuticals, Inc.34$25,6652019–2021
ACADIA Pharmaceuticals Inc44$20,7472019–2025
Genentech USA, Inc.25$5,0362019–2025
Novartis Pharmaceuticals Corporation85$2,3432019–2025
ABBVIE INC.113$2,2622019–2025
Alexion Pharmaceuticals, Inc.36$1,0922019–2025
MDD US Operations, LLC44$1,0762019–2025
Teva Pharmaceuticals USA, Inc.56$9842019–2025
Amgen Inc.35$8392019–2023
UCB, Inc.39$7542019–2025
Neurocrine BioSciences, Inc.33$4902021–2025
PFIZER INC.28$4692023–2025
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.20$4592022
Janssen Pharmaceuticals, Inc19$4412020–2022
SK Life Science, Inc.21$3752021–2025
Allergan, Inc.29$3712019–2022
Biohaven Pharmaceuticals, Inc.18$3582021
Amneal Pharmaceuticals LLC17$3292019–2025
Acorda Therapeutics, Inc20$3222020–2024
Horizon Therapeutics plc11$3152021–2022
Sunovion Pharmaceuticals Inc.16$2682020–2022
Lundbeck LLC9$1652020–2025
TG Therapeutics, Inc.5$1552023–2025
E.R. Squibb & Sons, L.L.C.3$1482020–2022
ARGENX US, INC.6$1432022–2025
Axsome Therapeutics, Inc.7$1362024–2025
Abbott Laboratories1$1282022
Supernus Pharmaceuticals, Inc.6$982021–2022
JAZZ PHARMACEUTICALS INC.5$952019–2025
CSL Behring7$952020–2022
KYOWA KIRIN, INC.4$942020–2024
Genentech, Inc.3$892019–2021
Amylyx Pharmaceuticals, Inc.5$842023
AstraZeneca Pharmaceuticals LP5$802021–2025
Ipsen Biopharmaceuticals, Inc5$742022–2024
Grifols USA, LLC4$732019–2025
Otsuka America Pharmaceutical, Inc.3$722023–2024
Adamas Pharmaceuticals, Inc.5$712020–2021
Takeda Pharmaceuticals U.S.A., Inc.3$592025
Merz Pharmaceuticals, LLC3$562023–2025
Celgene Corporation3$512021–2022
Zyla Life Sciences, Inc.3$392019–2020
Vanda Pharmaceuticals Inc.1$392025
Octapharma USA, Inc.2$392023–2024

By nature of payment

NatureRecordsAmount
Compensation for services other than consulting, including serving as faculty or as a speaker at a v154$425,785
Ownership or investment interest2$266,513
Travel and Lodging97$54,438
Consulting Fee32$49,763
Food and Beverage1,200$31,498
Compensation for serving as faculty or as a speaker for a medical education program14$19,597
Research payment6$14,525
Education11$587

Records

DateCompanyAmountNatureFormProductStudyYear
2025-12-30EMD Serono, Inc.$690Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentMavenclad Drug, Neurology2025
2025-12-22Eisai Inc.$110Consulting FeeCash or cash equivalentLeqembi Drug, Neurology2025
2025-12-22Neurelis, Inc.$18Food and BeverageIn-kind items and servicesVALTOCO Drug, EPILEPSY2025
2025-12-19GENZYME CORPORATION$29Food and BeverageIn-kind items and services2025
2025-12-19ABBVIE INC.$2Food and BeverageIn-kind items and servicesUBRELVY Drug, NEUROSCIENCE2025
2025-12-19ABBVIE INC.$1Food and BeverageIn-kind items and servicesQULIPTA Drug, NEUROSCIENCE2025
2025-12-15Axsome Therapeutics, Inc.$23Food and BeverageIn-kind items and servicesSymbravo Drug, Neurology2025
2025-12-11Grifols USA, LLC$24Food and BeverageIn-kind items and servicesGamunex-C Biological, Immunology and Neurology2025
2025-12-01EMD Serono, Inc.$3,795Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentMavenclad Drug, Neurology2025
2025-11-26Eisai Inc.$1,300Consulting FeeCash or cash equivalentLeqembi Drug, Neurology2025
2025-11-20MDD US Operations, LLC$21Food and BeverageIn-kind items and services2025
2025-11-20MDD US Operations, LLC$2Food and BeverageIn-kind items and services2025
2025-11-19Biogen, Inc.$16Food and BeverageIn-kind items and servicesVUMERITY Drug, Neurology2025
2025-11-17Amneal Pharmaceuticals LLC$23Food and BeverageIn-kind items and servicesCREXONT Drug, NEUROLOGY2025
2025-11-13EMD Serono, Inc.$127Food and BeverageCash or cash equivalent2025
2025-11-11MDD US Operations, LLC$8Food and BeverageIn-kind items and services2025
2025-11-06EMD Serono, Inc.$25Food and BeverageCash or cash equivalent2025
2025-11-05EMD Serono, Inc.$73Food and BeverageCash or cash equivalentMavenclad Drug, Neurology2025
2025-11-04Amneal Pharmaceuticals LLC$25Food and BeverageIn-kind items and servicesCREXONT Drug, NEUROLOGY2025
2025-11-04MDD US Operations, LLC$8Food and BeverageIn-kind items and services2025
2025-11-03ACADIA Pharmaceuticals Inc$24Food and BeverageIn-kind items and servicesNUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS2025
2025-10-30Lilly USA, LLC$2,100Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKISUNLA Drug, Neuroscience2025
2025-10-30Lilly USA, LLC$1,325Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKISUNLA Drug, Neuroscience2025
2025-10-30UCB, Inc.$21Food and BeverageIn-kind items and servicesNayzilam Drug, Neurology2025
2025-10-30ABBVIE INC.$6Food and BeverageIn-kind items and servicesQULIPTA Drug, NEUROSCIENCE2025
2025-10-29Lilly USA, LLC$27Food and BeverageIn-kind items and servicesAMYVID Drug, Neuroscience2025
2025-10-29Eisai Inc.$17Food and BeverageIn-kind items and servicesLeqembi Drug, Neurology2025
2025-10-27ABBVIE INC.$22Food and BeverageIn-kind items and servicesUBRELVY Drug, NEUROSCIENCE2025
2025-10-24Lilly USA, LLC$801Travel and LodgingIn-kind items and services2025
2025-10-22Lilly USA, LLC$1,312Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKISUNLA Drug, Neuroscience2025
2025-10-22ABBVIE INC.$26Food and BeverageIn-kind items and servicesVYALEV Drug, NEUROSCIENCE2025
2025-10-22ABBVIE INC.$26Food and BeverageIn-kind items and servicesVYALEV Drug, NEUROSCIENCE2025
2025-10-21Lilly USA, LLC$2,100Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKISUNLA Drug, Neuroscience2025
2025-10-21Lilly USA, LLC$800Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKISUNLA Drug, Neuroscience2025
2025-10-21Axsome Therapeutics, Inc.$25Food and BeverageIn-kind items and servicesSymbravo Drug, Neurology2025
2025-10-21Axsome Therapeutics, Inc.$22Food and BeverageIn-kind items and servicesSymbravo Drug, Neurology2025
2025-10-16Lilly USA, LLC$121Food and BeverageCash or cash equivalentKISUNLA Drug, Neuroscience2025
2025-10-16GENZYME CORPORATION$28Food and BeverageIn-kind items and services2025
2025-10-10Amneal Pharmaceuticals LLC$26Food and BeverageIn-kind items and servicesCREXONT Drug, NEUROLOGY2025
2025-10-08Alexion Pharmaceuticals, Inc.$24Food and BeverageIn-kind items and servicesULTOMIRIS Biological, Rare Disease2025
2025-10-06Eisai Inc.$1,040Consulting FeeCash or cash equivalentLeqembi Drug, Neurology2025
2025-09-30Axsome Therapeutics, Inc.$18Food and BeverageIn-kind items and servicesSymbravo Drug, Neurology2025
2025-09-29ARGENX US, INC.$26Food and BeverageIn-kind items and servicesVYVGART Drug, Immunology2025
2025-09-23Lilly USA, LLC$2,100Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKISUNLA Drug, Neuroscience2025
2025-09-23Lilly USA, LLC$800Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKISUNLA Drug, Neuroscience2025
2025-09-22Vanda Pharmaceuticals Inc.$39Food and BeverageCash or cash equivalentPONVORY Drug, MULTIPLE SCLEROSIS2025
2025-09-19Takeda Pharmaceuticals U.S.A., Inc.$23Food and BeverageIn-kind items and servicesHYQVIA Biological, IMMUNOLOGY2025
2025-09-11Grifols USA, LLC$17Food and BeverageIn-kind items and servicesGamunex-C Biological, Immunology and Neurology2025
2025-09-10EMD Serono, Inc.$84Food and BeverageCash or cash equivalent2025
2025-09-09Biogen, Inc.$16Food and BeverageIn-kind items and servicesVUMERITY Drug, Neurology2025
2025-09-08Lilly USA, LLC$2,625Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKISUNLA Drug, Neuroscience2025
2025-09-08Lilly USA, LLC$18Food and BeverageIn-kind items and servicesAMYVID Drug, Neuroscience2025
2025-09-05Eisai Inc.$15Food and BeverageIn-kind items and servicesLeqembi Drug, Neurology2025
2025-09-02EMD Serono, Inc.$6,555Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentMavenclad Drug, Neurology2025
2025-09-02EMD Serono, Inc.$3,795Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentMavenclad Drug, Neurology2025
2025-08-29Eisai Inc.$30Food and BeverageIn-kind items and servicesLeqembi Drug, Neurology2025
2025-08-27JAZZ PHARMACEUTICALS INC.$24Food and BeverageIn-kind items and servicesXYWAV Drug, NEUROLOGY2025
2025-08-26Eisai Inc.$520Consulting FeeCash or cash equivalentLeqembi Drug, Neurology2025
2025-08-20UCB, Inc.$28Food and BeverageIn-kind items and servicesFintepla Drug, Neurology2025
2025-08-18ARGENX US, INC.$28Food and BeverageIn-kind items and servicesVYVGART HYTRULO Drug, Neurology2025
2025-08-18Eisai Inc.$24Food and BeverageIn-kind items and servicesLeqembi Drug, Neurology2025
2025-08-12EMD Serono, Inc.$517Travel and LodgingCash or cash equivalentMavenclad Drug, Neurology2025
2025-08-05MDD US Operations, LLC$21Food and BeverageIn-kind items and services2025
2025-08-05MDD US Operations, LLC$8Food and BeverageIn-kind items and services2025
2025-08-04ABBVIE INC.$19Food and BeverageIn-kind items and servicesQULIPTA Drug, NEUROSCIENCE2025
2025-07-30ABBVIE INC.$19Food and BeverageIn-kind items and servicesVYALEV Drug, NEUROSCIENCE2025
2025-07-24UCB, Inc.$25Food and BeverageIn-kind items and servicesFintepla Drug, Neurology2025
2025-07-22Teva Pharmaceuticals USA, Inc.$91EducationIn-kind items and services2025
2025-07-16EMD Serono, Inc.$3,795Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentMavenclad Drug, Neurology2025
2025-07-14Genentech USA, Inc.$19Food and BeverageIn-kind items and servicesOcrevus Biological, Immunology2025
2025-07-10Lilly USA, LLC$22Food and BeverageIn-kind items and servicesKISUNLA Drug, Neuroscience2025
2025-07-09Biogen, Inc.$15Food and BeverageIn-kind items and servicesTYSABRI Biological, Neurology2025
2025-07-02Axsome Therapeutics, Inc.$13Food and BeverageIn-kind items and servicesSymbravo Drug, Neurology2025
2025-07-01EMD Serono, Inc.$6,555Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentMavenclad Drug, Neurology2025
2025-07-01MDD US Operations, LLC$8Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentApokyn Drug, APOMORPHINE HYDROCHLORIDE2025
2025-06-30Eisai Inc.$22Food and BeverageIn-kind items and servicesLeqembi Drug, Neurology2025
2025-06-27Eisai Inc.$1,121Travel and LodgingCash or cash equivalentLeqembi Drug, Neurology2025
2025-06-24Eisai Inc.$1,755Compensation for serving as faculty or as a speaker for a medical education programCash or cash equivalentLeqembi Drug, Neurology2025
2025-06-24Eisai Inc.$1,462Compensation for serving as faculty or as a speaker for a medical education programCash or cash equivalentLeqembi Drug, Neurology2025
2025-06-24Eisai Inc.$121Food and BeverageCash or cash equivalentLeqembi Drug, Neurology2025
2025-06-23EMD Serono, Inc.$22Food and BeverageCash or cash equivalent2025
2025-06-21PFIZER INC.$15Food and BeverageIn-kind items and servicesNURTEC ODT Drug, PAIN2025
2025-06-19EMD Serono, Inc.$50Food and BeverageCash or cash equivalentMavenclad Drug, Neurology2025
2025-06-17Genentech USA, Inc.$22Food and BeverageIn-kind items and servicesOcrevus Biological, Immunology2025
2025-06-14ABBVIE INC.$26Food and BeverageIn-kind items and servicesVYALEV Drug, NEUROSCIENCE2025
2025-06-13ABBVIE INC.$9Food and BeverageIn-kind items and servicesQULIPTA Drug, NEUROSCIENCE2025
2025-06-12Merz Pharmaceuticals, LLC$22Food and BeverageIn-kind items and servicesXeomin Biological, Musculoskeletal2025
2025-06-11Alexion Pharmaceuticals, Inc.$22Food and BeverageIn-kind items and servicesULTOMIRIS Biological, Rare Disease2025
2025-06-11Novartis Pharmaceuticals Corporation$16Food and BeverageIn-kind items and servicesKESIMPTA Drug, Neurology2025
2025-06-09EMD Serono, Inc.$1,341Travel and LodgingCash or cash equivalentMavenclad Drug, Neurology2025
2025-06-09EMD Serono, Inc.$150Food and BeverageCash or cash equivalentMavenclad Drug, Neurology2025
2025-06-09EMD Serono, Inc.$65Travel and LodgingCash or cash equivalentMavenclad Drug, Neurology2025
2025-06-04MDD US Operations, LLC$17Food and BeverageIn-kind items and services2025
2025-06-03MDD US Operations, LLC$6Food and BeverageIn-kind items and services2025
2025-06-02Lilly USA, LLC$2,100Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKISUNLA Drug, Neuroscience2025
2025-06-02Lilly USA, LLC$1,325Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKISUNLA Drug, Neuroscience2025
2025-05-29UCB, Inc.$24Food and BeverageIn-kind items and servicesFintepla Drug, Neurology2025
2025-05-28Lilly USA, LLC$915Travel and LodgingIn-kind items and services2025
2025-05-28Lilly USA, LLC$54Food and BeverageCash or cash equivalentKISUNLA Drug, Neuroscience2025
2025-05-28UCB, Inc.$17Food and BeverageIn-kind items and servicesFintepla Drug, Neurology2025
2025-05-28ABBVIE INC.$13Food and BeverageIn-kind items and servicesVYALEV Drug, NEUROSCIENCE2025
2025-05-23EMD Serono, Inc.$10,005Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentMavenclad Drug, Neurology2025
2025-05-23Lilly USA, LLC$1,050Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKISUNLA Drug, Neuroscience2025
2025-05-23Lilly USA, LLC$1,050Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKISUNLA Drug, Neuroscience2025
2025-05-21SK Life Science, Inc.$25Food and BeverageIn-kind items and services2025
2025-05-21PFIZER INC.$15Food and BeverageIn-kind items and servicesPANZYGA Biological, IMMUNOLOGY;INFLAMMATION2025
2025-05-20PFIZER INC.$14Food and BeverageIn-kind items and servicesNURTEC ODT Drug, PAIN2025
2025-05-14Lilly USA, LLC$2,100Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKISUNLA Drug, Neuroscience2025
2025-05-14Lilly USA, LLC$800Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKISUNLA Drug, Neuroscience2025
2025-05-13ABBVIE INC.$11Food and BeverageIn-kind items and servicesVYALEV Drug, NEUROSCIENCE2025
2025-05-13MDD US Operations, LLC$7Food and BeverageIn-kind items and servicesGocovri Drug, AMANTADINE2025
2025-05-12ABBVIE INC.$17Food and BeverageIn-kind items and servicesBOTOX Biological, BOTOX THERAPEUTIC2025
2025-05-12MDD US Operations, LLC$16Food and BeverageIn-kind items and services2025
2025-05-09Eisai Inc.$182Consulting FeeCash or cash equivalentLeqembi Drug, Neurology2025
2025-05-09Eisai Inc.$110Consulting FeeCash or cash equivalentLeqembi Drug, Neurology2025
2025-05-07Lilly USA, LLC$124Food and BeverageCash or cash equivalentKISUNLA Drug, Neuroscience2025
2025-05-07Amneal Pharmaceuticals LLC$20Food and BeverageIn-kind items and servicesCREXONT Drug, NEUROLOGY2025
2025-05-05Biogen, Inc.$18Food and BeverageIn-kind items and servicesTYSABRI Biological, Neurology2025
2025-05-03ABBVIE INC.$19Food and BeverageIn-kind items and servicesQULIPTA Drug, NEUROSCIENCE2025
2025-05-03Lilly USA, LLC$6Food and BeverageIn-kind items and servicesAMYVID Drug, Neuroscience2025
2025-05-01ABBVIE INC.$20Food and BeverageIn-kind items and servicesBOTOX Biological, BOTOX THERAPEUTIC2025
2025-04-30Eisai Inc.$1,462Compensation for serving as faculty or as a speaker for a medical education programCash or cash equivalentLeqembi Drug, Neurology2025
2025-04-30Eisai Inc.$585Compensation for serving as faculty or as a speaker for a medical education programCash or cash equivalentLeqembi Drug, Neurology2025
2025-04-30Eisai Inc.$67Food and BeverageCash or cash equivalentLeqembi Drug, Neurology2025
2025-04-30AstraZeneca Pharmaceuticals LP$15Food and BeverageIn-kind items and servicesWAINUA Drug, Cardiovascular and Metabolism2025
2025-04-28Amneal Pharmaceuticals LLC$20Food and BeverageIn-kind items and servicesCREXONT Drug, NEUROLOGY2025
2025-04-23SK Life Science, Inc.$14Food and BeverageIn-kind items and services2025
2025-04-23ABBVIE INC.$12Food and BeverageIn-kind items and servicesQULIPTA Drug, NEUROSCIENCE2025
2025-04-21ABBVIE INC.$19Food and BeverageIn-kind items and servicesVYALEV Drug, NEUROSCIENCE2025
2025-04-16Eisai Inc.$29Food and BeverageIn-kind items and servicesLeqembi Drug, Neurology2025
2025-04-05EMD Serono, Inc.$90Food and BeverageCash or cash equivalent2025
2025-04-05EMD Serono, Inc.$75Food and BeverageCash or cash equivalent2025
2025-04-05EMD Serono, Inc.$31Food and BeverageCash or cash equivalent2025
2025-04-04EMD Serono, Inc.$319Travel and LodgingCash or cash equivalent2025
2025-04-04EMD Serono, Inc.$184Food and BeverageCash or cash equivalent2025
2025-04-01ACADIA Pharmaceuticals Inc$29Food and BeverageIn-kind items and servicesNUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS2025
2025-03-31PFIZER INC.$16Food and BeverageIn-kind items and servicesNURTEC ODT Drug, PAIN2025
2025-03-26Biogen, Inc.$23Food and BeverageIn-kind items and servicesVUMERITY Drug, Neurology2025
2025-03-25ABBVIE INC.$17Food and BeverageIn-kind items and servicesVYALEV Drug, NEUROSCIENCE2025
2025-03-24Takeda Pharmaceuticals U.S.A., Inc.$22Food and BeverageIn-kind items and servicesHYQVIA Biological, IMMUNOLOGY2025
2025-03-17MDD US Operations, LLC$23Food and BeverageIn-kind items and servicesGocovri Drug, AMANTADINE2025
2025-03-14EMD Serono, Inc.$6,555Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentMavenclad Drug, Neurology2025
2025-03-14EMD Serono, Inc.$44Food and BeverageCash or cash equivalent2025
2025-03-13EMD Serono, Inc.$1,707Travel and LodgingCash or cash equivalentMavenclad Drug, Neurology2025
2025-03-13EMD Serono, Inc.$65Travel and LodgingCash or cash equivalentMavenclad Drug, Neurology2025
2025-03-13EMD Serono, Inc.$47Food and BeverageCash or cash equivalentMavenclad Drug, Neurology2025
2025-03-12UCB, Inc.$66Food and BeverageIn-kind items and servicesZilbrysq Drug, Neurology2025
2025-03-12UCB, Inc.$58Food and BeverageIn-kind items and servicesZilbrysq Drug, Neurology2025
2025-03-11ABBVIE INC.$33Food and BeverageIn-kind items and servicesQULIPTA Drug, NEUROSCIENCE2025
2025-03-11MDD US Operations, LLC$5Food and BeverageIn-kind items and servicesGocovri Drug, AMANTADINE2025
2025-03-07Novartis Pharmaceuticals Corporation$15Food and BeverageIn-kind items and servicesKESIMPTA Drug, Neurology2025
2025-03-05EMD Serono, Inc.$63Food and BeverageCash or cash equivalent2025
2025-03-05MDD US Operations, LLC$18Food and BeverageIn-kind items and servicesGocovri Drug, AMANTADINE2025
2025-03-04Teva Pharmaceuticals USA, Inc.$16Food and BeverageIn-kind items and servicesAUSTEDO XR Drug, Central Nervous System2025
2025-03-03PFIZER INC.$19Food and BeverageIn-kind items and servicesPANZYGA Biological, IMMUNOLOGY;INFLAMMATION2025
2025-02-21PFIZER INC.$29Food and BeverageIn-kind items and servicesPANZYGA Biological, IMMUNOLOGY;INFLAMMATION2025
2025-02-20EMD Serono, Inc.$65Travel and LodgingCash or cash equivalentMavenclad Drug, Neurology2025
2025-02-19EMD Serono, Inc.$109Food and BeverageCash or cash equivalent2025
2025-02-19EMD Serono, Inc.$20Food and BeverageCash or cash equivalent2025
2025-02-18Eisai Inc.$23Food and BeverageIn-kind items and servicesLeqembi Drug, Neurology2025
2025-02-17EMD Serono, Inc.$105Food and BeverageCash or cash equivalent2025
2025-02-17UCB, Inc.$14Food and BeverageIn-kind items and servicesBriviact Drug, Neurology2025
2025-02-11Lundbeck LLC$18Food and BeverageCash or cash equivalentVYEPTI Biological, NEUROLOGY2025
2025-02-10Genentech USA, Inc.$23Food and BeverageIn-kind items and servicesOcrevus Zunovo Biological, Immunology2025
2025-01-30EMD Serono, Inc.$345Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentMavenclad Drug, Neurology2025
2025-01-30Lilly USA, LLC$22Food and BeverageIn-kind items and servicesKISUNLA Drug, Neuroscience2025
2025-01-29Teva Pharmaceuticals USA, Inc.$17Food and BeverageIn-kind items and servicesAUSTEDO XR Drug, Central Nervous System2025
2025-01-28Eisai Inc.$23Food and BeverageIn-kind items and servicesLeqembi Drug, Neurology2025
2025-01-24EMD Serono, Inc.$16Food and BeverageCash or cash equivalent2025
2025-01-23Novartis Pharmaceuticals Corporation$15Food and BeverageIn-kind items and servicesKESIMPTA Drug, Neurology2025
2025-01-22Eisai Inc.$1,462Compensation for serving as faculty or as a speaker for a medical education programCash or cash equivalentLeqembi Drug, Neurology2025
2025-01-22Eisai Inc.$585Compensation for serving as faculty or as a speaker for a medical education programCash or cash equivalentLeqembi Drug, Neurology2025
2025-01-22Eisai Inc.$120Food and BeverageCash or cash equivalentLeqembi Drug, Neurology2025
2025-01-22ABBVIE INC.$25Food and BeverageIn-kind items and servicesBOTOX Biological, BOTOX THERAPEUTIC2025
2025-01-22Takeda Pharmaceuticals U.S.A., Inc.$13Food and BeverageIn-kind items and servicesHYQVIA Biological, IMMUNOLOGY2025
2025-01-17TG Therapeutics, Inc.$18Food and BeverageIn-kind items and servicesBRIUMVI Drug, Immunology2025
2025-01-16ABBVIE INC.$10Food and BeverageIn-kind items and servicesQULIPTA Drug, NEUROSCIENCE2025
2025-01-15UCB, Inc.$18Food and BeverageIn-kind items and servicesFintepla Drug, Neurology2025
2025-01-14Neurocrine BioSciences, Inc.$17Food and BeverageIn-kind items and servicesINGREZZA Drug, Neuropsychiatry2025
2025-01-09SK Life Science, Inc.$21Food and BeverageIn-kind items and services2025
2025-01-03EMD Serono, Inc.$3,273Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentMavenclad Drug, Neurology2025
2024-12-30Grifols USA, LLC$18Food and BeverageIn-kind items and servicesGamunex-C Biological, Immunology and Neurology2024
2024-12-03MDD US Operations, LLC$14Food and BeverageIn-kind items and servicesGocovri Drug, AMANTADINE2024
2024-12-03Lilly USA, LLC$10Food and BeverageIn-kind items and servicesEMGALITY Drug, Neuroscience2024
2024-11-27PFIZER INC.$13Food and BeverageIn-kind items and servicesPANZYGA Biological, IMMUNOLOGY;INFLAMMATION2024
2024-11-20Eisai Inc.$33Food and BeverageIn-kind items and servicesLeqembi Drug, Neurology2024
2024-11-19EMD Serono, Inc.$3,273Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentMavenclad Drug, Neurology2024
2024-11-18ABBVIE INC.$19Food and BeverageIn-kind items and servicesBOTOX Biological, BOTOX THERAPEUTIC2024
2024-11-15EMD Serono, Inc.$62Food and BeverageCash or cash equivalent2024
2024-11-12EMD Serono, Inc.$27Food and BeverageCash or cash equivalent2024
2024-11-10Biogen, Inc.$18Food and BeverageIn-kind items and servicesVUMERITY Drug, Neurology2024
2024-11-08Novartis Pharmaceuticals Corporation$17Food and BeverageIn-kind items and servicesKESIMPTA Drug, Neurology2024
2024-11-07Lilly USA, LLC$12Food and BeverageIn-kind items and servicesEMGALITY Drug, Neuroscience2024
2024-11-03MDD US Operations, LLC$19Food and BeverageIn-kind items and servicesGocovri Drug, AMANTADINE2024
2024-11-03MDD US Operations, LLC$5Food and BeverageIn-kind items and servicesGocovri Drug, AMANTADINE2024
2024-10-31ABBVIE INC.$17Food and BeverageIn-kind items and servicesQULIPTA Drug, NEUROSCIENCE2024
2024-10-30Axsome Therapeutics, Inc.$17Food and BeverageIn-kind items and servicesSunosi Drug, Neurology2024
2024-10-30EMD Serono, Inc.$9Food and BeverageCash or cash equivalent2024
2024-10-29Eisai Inc.$29Food and BeverageIn-kind items and servicesLeqembi Drug, Neurology2024
2024-10-28Lilly USA, LLC$2,100Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKISUNLA Drug, Neuroscience2024

The latest 200 records of 1,516.

Research payments naming this person as principal investigator

DateCompanyPaid toAmountStudyYear
2025-12-22GENZYME CORPORATIONInterspond Llc$471An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participa2025
2025-10-20GENZYME CORPORATIONInterspond Llc$3,000An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participa2025
2025-10-20GENZYME CORPORATIONInterspond Llc$1,960An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participa2025
2025-10-20GENZYME CORPORATIONInterspond Llc$2,000An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participa2025
2025-10-20GENZYME CORPORATIONInterspond Llc$1,845An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participa2025
2025-10-20GENZYME CORPORATIONInterspond Llc$465An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participa2025
2025-09-03GENZYME CORPORATIONInterspond Llc$25,574An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participa2025
2025-08-11GENZYME CORPORATIONInterspond Llc$1,669An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participa2025
2025-07-14GENZYME CORPORATIONInterspond Llc$976An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participa2025
2025-07-14GENZYME CORPORATIONInterspond Llc$511An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participa2025
2025-07-14GENZYME CORPORATIONInterspond Llc$511An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participa2025
2025-06-09GENZYME CORPORATIONInterspond Llc$69,244An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participa2025
2025-05-19GENZYME CORPORATIONInterspond Llc$7,500A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2025
2025-05-12GENZYME CORPORATIONInterspond Llc$7,500A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2025
2025-04-02GENZYME CORPORATIONInterspond Llc$1,029An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participa2025
2025-03-24GENZYME CORPORATIONInterspond Llc$3,000An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participa2025
2025-02-18GENZYME CORPORATIONInterspond Llc$657An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participa2025
2025-01-27GENZYME CORPORATIONInterspond Llc$6,699A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2025
2025-01-24GENZYME CORPORATIONInterspond Llc$790An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participa2025
2025-01-16ABBVIE INC.Interspond Llc$175Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson s Disease With Motor Fluctuations (TEMPO-3)2025
2024-12-16GENZYME CORPORATIONInterspond Llc$750A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2024
2024-12-16GENZYME CORPORATIONInterspond Llc$1,012A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2024
2024-12-12ABBVIE INC.Interspond Llc$6,550Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson s Disease With Motor Fluctuations (TEMPO-3)2024
2024-12-09GENZYME CORPORATIONInterspond Llc$4,416An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participa2024
2024-12-09GENZYME CORPORATIONInterspond Llc$1,116An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participa2024
2024-11-12GENZYME CORPORATIONInterspond Llc$1,104An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participa2024
2024-11-04GENZYME CORPORATIONInterspond Llc$17,634An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participa2024
2024-11-04GENZYME CORPORATIONInterspond Llc$18,426An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participa2024
2024-11-04GENZYME CORPORATIONInterspond Llc$832An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participa2024
2024-11-04GENZYME CORPORATIONInterspond Llc$1,209An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participa2024
2024-10-28GENZYME CORPORATIONInterspond Llc$1,255An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participa2024
2024-10-15GENZYME CORPORATIONInterspond Llc$6,931A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2024
2024-10-15GENZYME CORPORATIONInterspond Llc$71,158A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2024
2024-08-26GENZYME CORPORATIONInterspond Llc$63,950A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2024
2024-08-05GENZYME CORPORATIONInterspond Llc$519A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2024
2024-07-22GENZYME CORPORATIONInterspond Llc$21,625A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2024
2024-07-15GENZYME CORPORATIONInterspond Llc$1,763A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2024
2024-07-02GENZYME CORPORATIONInterspond Llc$290A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2024
2024-06-04GENZYME CORPORATIONInterspond Llc$4,731A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2024
2024-06-04GENZYME CORPORATIONInterspond Llc$562A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2024
2024-04-22GENZYME CORPORATIONInterspond Llc$7,097A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2024
2024-03-25GENZYME CORPORATIONInterspond Llc$5,337A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2024
2024-03-04GENZYME CORPORATIONInterspond Llc$736A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2024
2024-02-26GENZYME CORPORATIONInterspond Llc$31,751A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2024
2024-02-20GENZYME CORPORATIONInterspond Llc$513A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2024
2024-02-05GENZYME CORPORATIONInterspond Llc$668A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2024
2024-02-05GENZYME CORPORATIONInterspond Llc$772A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2024
2024-01-22GENZYME CORPORATIONInterspond Llc$27,907A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2024
2023-12-18GENZYME CORPORATIONInterspond Llc$2,274A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2023
2023-12-11GENZYME CORPORATIONInterspond Llc$663A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2023
2023-11-20GENZYME CORPORATIONInterspond Llc$11,449A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2023
2023-10-30GENZYME CORPORATIONInterspond Llc$19,122A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2023
2023-09-18GENZYME CORPORATIONInterspond Llc$14,515A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2023
2023-08-28GENZYME CORPORATIONInterspond Llc$322A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2023
2023-08-14GENZYME CORPORATIONInterspond Llc$19,414A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2023
2023-08-02GENZYME CORPORATIONInterspond Llc$6,882A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2023
2023-07-24GENZYME CORPORATIONInterspond Llc$13,488A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2023
2023-07-17GENZYME CORPORATIONInterspond Llc$740A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2023
2023-05-25GENZYME CORPORATIONInterspond Llc$925A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2023
2023-05-25GENZYME CORPORATIONInterspond Llc$15,999A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2023
2023-04-24GENZYME CORPORATIONInterspond Llc$1,278A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2023
2023-04-24GENZYME CORPORATIONInterspond Llc$28,152A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2023
2023-04-04GENZYME CORPORATIONInterspond Llc$355A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2023
2023-04-04GENZYME CORPORATIONInterspond Llc$1,454A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2023
2023-03-27GENZYME CORPORATIONInterspond Llc$597A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2023
2023-03-20GENZYME CORPORATIONInterspond Llc$11,724A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2023
2023-03-20GENZYME CORPORATIONInterspond Llc$916A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2023
2023-02-27GENZYME CORPORATIONInterspond Llc$2,000A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2023
2023-02-27GENZYME CORPORATIONInterspond Llc$16,581A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2023
2023-02-06GENZYME CORPORATIONInterspond Llc$1,000A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2023
2023-02-06GENZYME CORPORATIONInterspond Llc$27,641A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2023
2023-01-30GENZYME CORPORATIONInterspond Llc$22,884A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2023
2023-01-11Biogen, Inc.Dayton Center Of Neurological Disorders$911A Prospective Real-World Observational Study Of Aducanumab In Patients With Alzheimers Disease: ICARE AD US2023
2022-12-05GENZYME CORPORATIONInterspond Llc$655A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022
2022-12-05GENZYME CORPORATIONInterspond Llc$3,000A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022
2022-12-05GENZYME CORPORATIONInterspond Llc$43A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022
2022-11-02GENZYME CORPORATIONInterspond Llc$6,090A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022
2022-10-11GENZYME CORPORATIONInterspond Llc$58,650A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022
2022-10-11GENZYME CORPORATIONInterspond Llc$1,517A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022
2022-10-04GENZYME CORPORATIONInterspond Llc$37,097A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022
2022-09-26GENZYME CORPORATIONInterspond Llc$35,974A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022
2022-09-12GENZYME CORPORATIONInterspond Llc$12,420A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022
2022-09-06GENZYME CORPORATIONInterspond Llc$14,863A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022
2022-09-06GENZYME CORPORATIONInterspond Llc$463A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022
2022-07-18GENZYME CORPORATIONInterspond Llc$1,200A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022
2022-07-05GENZYME CORPORATIONInterspond Llc$505A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022
2022-06-28GENZYME CORPORATIONInterspond Llc$25,098A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022
2022-06-15Eli Lilly and CompanyInterspond Llc$7,964A STUDY OF HEALTH CARE USE AND COSTS IN PARTICIPANTS WITH EARLY STAGE ALZHEIMER'S DISEASE AD GERAS US2022
2022-06-06GENZYME CORPORATIONInterspond Llc$411A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022
2022-06-02GENZYME CORPORATIONInterspond Llc$544A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022
2022-05-09GENZYME CORPORATIONInterspond Llc$63,588A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022
2022-04-11GENZYME CORPORATIONInterspond Llc$5,717A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022
2022-04-11GENZYME CORPORATIONInterspond Llc$1,449A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022
2022-04-11GENZYME CORPORATIONInterspond Llc$20,897A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022
2022-04-04GENZYME CORPORATIONInterspond Llc$777A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022
2022-04-04GENZYME CORPORATIONInterspond Llc$470A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022
2022-03-28GENZYME CORPORATIONInterspond Llc$250A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022
2022-01-18Biogen, Inc.Dayton Center Of Neurological Disorders$9,540A Prospective Real-World Observational Study Of Aducanumab In Patients With Alzheimers Disease: ICARE AD US2022
2022-01-04GENZYME CORPORATIONInterspond Llc$699A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022
2022-01-04GENZYME CORPORATIONInterspond Llc$1,367A Phase 3, Randomized, Double-blind Efficacy and Safety Study Comparing SAR442168 to Teriflunomide (Aubagio) in Particip2022

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Montgomery CountyCenterville city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Centerville, OH, county Montgomery County, OH, state Ohio; placed by its city name.

MeasurePlace (city or town)
Centerville, OH
County
Montgomery County, OH
State
Ohio
Population B0100325,205536,09611,810,293
Population, 2020 census P124,240537,30911,799,448
Median age B0100246.438.839.7
Under 18 B0100119.3%22.2%22.0%
65 and over B0100129.0%18.6%18.3%
Households B1100111,829231,3194,863,191
Foreign born B050026.8%5.3%5.2%
Median household income B19013$85,492$66,139$71,389
Median family income B19113$115,308$87,506$92,749
Per capita income B19301$50,775$38,450$40,552
Poverty rate B170018.6%15.0%13.3%
Unemployment rate B230253.4%5.7%4.8%
Civilian labor force B2302512,634269,8105,994,779
Mean commute (minutes) B0801320.421.923.4
Bachelor's degree or higher B1500347.3%31.3%31.5%
Housing units B2500112,143252,8435,292,391
Owner-occupied B2500367.0%62.5%67.2%
Renters B2500333.0%37.5%32.8%
Median home value B25077$287,200$180,900$214,800
Median gross rent B25064$1,270$1,026$1,034
White, not Hispanic B0300281.7%67.7%75.8%
Black B030026.2%20.4%12.0%
Hispanic or Latino B030025.7%4.2%4.8%
Asian B030022.2%2.2%2.5%
American Indian and Alaska Native B030020.0%0.0%0.1%

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Centerville, OH.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.